Recent research conducted by CSO and president of EVIO Labs Inc. (OTC: EVIO) Anthony Smith and M.J. Murdock Metabolomics Lab director Bernd Markus Lange, together with their colleagues, may be useful to marijuana consumers, producers and breeders. The researchers examined various data sets to differentiate marijuana strains.
Each strain of marijuana contains different concentrations of cannabinoids, including CBD, which is nonpsychoactive, and THC, which is psychoactive. This allows consumers to choose marijuana based on desired effects, such as particular aromas and relaxation. However, the genetic information that makes up these differences isn’t well understood.
This is why the researchers’ discoveries will be useful, as they will help make sure that consumers choose products that have been labeled appropriately and come in handy in new cultivar development. Additionally, the findings will enable marijuana producers and breeders to determine the type of cannabinoid and sex of young plants.
Lange, who is also a professor at the Institute of Biological Chemistry, explained that terpenoids and cannabinoids were mainly concentrated in marijuana flowers, with Smith adding that despite this, they didn’t share the same biosynthetic pathways. For their study, the researchers from Cornell University’s School of Integrative Plant Science designed assays to help determine cannabinoid type and sex of cultivars, which are young plants.
One of the researchers, Jacob Toth, explained that cultivars shared chemical, physiological and morphological characteristics, noting that they discovered that some plants produced just as much CBD as THC. Toth observed that plants which produced more levels of THC were problematic, which emphasized the need to develop a way to identify plants that produce too much THC to assist growers in remaining compliant.
The researchers used algorithms and RNA-seq to identify distinct gene networks in marijuana strains. In addition to this, they also quantified and separated terpenoids and cannabinoids through the use of liquid chromatography and gas chromatography, with their findings demonstrating a correlation between terpenoid and cannabinoid products and biosynthetic genes.
Lange noted that this showed that marijuana strains could be differentiated by conducting an analysis of transcriptomic and metabolic data sets. He added that the marijuana industry as a whole would benefit from genetic testing, as it would allow them to label various strains correctly.
Furthermore, Smith explained how transcriptomic, genomic or metabolic data could serve different purposes, noting that while the first two were markets growers would need in order to validate their engineering and breeding efforts, the latter could be utilized as a benchmark for developing and studying cultivars for therapeutic needs and consumer interests. This, he said, would drive therapeutic research and product preference.
A number of marijuana companies such as Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) are already leveraging the power of genetics in order to produce superior products, so it is just a matter of time before genetic testing is used in all aspects of the industry.
NOTE TO INVESTORS: The latest news and updates relating to Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) are available in the company’s newsroom at http://cnw.fm/PACR
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
